IBM pitched its Watson supercomputer as a revolution in cancer care. It's nowhere close
www.statnews.com/2017/09/05/watson-ibm-cancer/
1 Users
0 Comments
2 Highlights
0 Notes
Tags
Top Highlights
The most prominent failure occurred last February when MD Anderson Cancer Center, part of the University of Texas, cancelled its partnership with Watson.
In all, MD Anderson spent more than three years and $60 million — much of it on outside consultants — before shelving the effort.
Ready to highlight and find good content?
Glasp is a social web highlighter that people can highlight and organize quotes and thoughts from the web, and access other like-minded people’s learning.